Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001185255 | SCV001351430 | likely benign | Cardiomyopathy | 2018-11-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005208746 | SCV001618232 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-07-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000231760 | SCV001797231 | uncertain significance | not provided | 2021-05-04 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In-silico analysis, which includes splice predictors and evolutionary conservation, is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Reported in ClinVar (ClinVar Variant ID# 238239; Landrum et al., 2016) |
Ambry Genetics | RCV002365180 | SCV002665055 | likely benign | Cardiovascular phenotype | 2018-08-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001416062 | SCV004816351 | likely benign | Catecholaminergic polymorphic ventricular tachycardia | 2023-12-01 | criteria provided, single submitter | clinical testing |